Impact Partnership Wealth’s Pfizer PFE Stock Holding History

Impact Partnership Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$259K	Buy	10,749 +349	+3%	+$9.13K	0.03%	370
2026 Q1	$292K	Sell	10,400 -20,422	-66%	-$544K	0.04%	278
2025 Q4	$767K	Buy	30,822 +6,823	+28%	+$172K	0.1%	138
2025 Q3	$611K	Buy	+23,999	New	+$592K	0.09%	139
2024 Q2	–	Sell	-882	Closed	-$24.5K	–	541
2024 Q1	$24.5K	Sell	882 -905	-51%	-$25.1K	0.01%	372
2023 Q4	$51.5K	Sell	1,787 -19,392	-92%	-$586K	0.02%	319
2023 Q3	$703K	Buy	21,179 +12,754	+151%	+$451K	0.22%	51
2023 Q2	$309K	Buy	+8,425	New	+$328K	0.11%	137

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Impact Partnership Wealth's PFE Position: Q2 2026 in Review

Impact Partnership Wealth increased its Pfizer (PFE) stake by 3.4% in Q2 2026, buying an estimated $9.13K and bringing the position to 10,749 shares worth $259K. The position accounts for 0.03% of the portfolio, ranked #370.

Impact Partnership Wealth first reported a position in PFE in Q2 2023 and has held it in 8 quarters since. The position peaked at $767K in Q4 2025. 2,836 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Impact Partnership Wealth held 10,749 shares of Pfizer worth $259K as of Q2 2026.
Impact Partnership Wealth bought 349 Pfizer shares in Q2 2026, an estimated $9.13K.
Pfizer made up 0.03% of Impact Partnership Wealth's portfolio in Q2 2026, its #370 holding.
Impact Partnership Wealth first reported a position in Pfizer in Q2 2023 and has held it in 8 quarters since.
Impact Partnership Wealth's Pfizer position peaked at $767K in Q4 2025.
2,836 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Impact Partnership Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.